Title : Rosiglitazone: potential beneficial impact on cardiovascular disease.

Pub. Date : 2003 Mar

PMID : 12661797






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As reviewed below, rosiglitazone has a beneficial impact on a number of factors associated with insulin resistance and CVD, including microalbuminuria, hypertension, dyslipidaemia, visceral fat, elevated plasminogen activator inhibitor-1 levels and increased concentrations of C-reactive protein. Rosiglitazone serpin family E member 1 Homo sapiens